BSECompany Update4 Nov 2026 · 4 Nov 2026, 07:00 pm
Please find attached Audio Recording of Investor Call.
Alembic Pharmaceuticals Ltd · 533573
✦ AI Summary
Alembic Pharmaceuticals Ltd has submitted the audio recording of its post-results conference call held on 4th November, 2026, which can be accessed on the company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
6fed8037-d3f6-4672-87e3-8acdc17f3c69.pdf
View document text
4th November, 2026
To, To,
The Manager, The Manager,
Department of Corporate Services, Listing Department,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 533573 NSE Symbol: APLLTD
Dear Sir/Madam,
Sub: Submission of Audio Recording of Post Results Conference Call held on
4th November, 2026
Ref: Our Intimation dated 30th October, 2026
With reference to the captioned subject, this is to inform the exchanges that the audio
recording has been hosted on the website of the Company and can be accessed at
https://alembicpharmaceuticals.com/quarterly-results
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
Chirag K. Shukla
Company Secretary
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123